Embrionic Stem Cells

FDA Approves Study Using Embryonic Stem Cells For Dry AMD

The FDA approved Advanced Cell Technology’s (ACT) clinical trial to test human embryonic stem cells for treating dry macular degeneration.  ACT makes retinal pigment epithelial cells from human embryonic stem cells and is starting to recruit patients for this study.  Court battles continue over the use of federal funds for stem cell research and funding gets frozen and unfrozen while the government  appeals. 

 

SEE FULL STORY

Syndicate content